is oral glp 1 fda approved Big news in obesity medicine: the has the first GLP-1 for weight loss. My commentary via @nbcnews FDA approves first oral GLP1

Adapting to the GLP-1 era is an ongoing journey

Type 2 diabetes is not inherently insulin-dependent

Quick Answer: GLP-1 receptor agonists are not officially linked to generalized sensitive skin, though injection site reactions occur in 2-10% of patients and rare allergic skin reactions have been reported

Connect with us today to schedule your online evaluation and take your first step towards a healthier life

2) We cant predict the response

For most patients, standard-dose semaglutide or tirzepatide is more likely to produce faster and more noticeable weight loss because the dose strategy is designed to reach stronger appetite-suppressing levels over time